Together, we explore novel compounds in clinical development, many with potential best-in-class status, aiming to advance or create new
standards of care.
See compounds in all phases of development, from preclinical studies through large, randomized Phase III trials.
Explore our interactive pipeline
Novartis is currently conducting clinical trials in a number of disease areas. Learn more